Back

Inter-individual variability in LDL-C reductions with inclisiran - Data from ORION-10 and ORION-11

1 September 2020 (08:50 - 09:00)
Organised by:
Congress Presentation Part of: Deep Dive in Risk Factors and Prevention Drug therapy ESC Premium Access ESC Congress 2020

About the speaker

Photo
Professor R Scott Wright

Mayo Clinic, Rochester (United States of America)

2 More presentations in this session

Presentation thumbnail
The Finnish Diabetes Risk Score (FINDRISC) and incident diabetes and low-grade inflammation
Doctor A. Pesaro (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
High-density lipoprotein cholesterol does not predict future cardiovascular events in patients treated with statins for secondary prevention: an observation from the REAL-CAD study
Associate Professor T. Nagai (Sapporo, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Deep Dive in Risk Factors and Prevention

The Event

Event poster

ESC Congress 2020

1 September 2020 08:50 CET
You may be interested in
thumbnail
Congress Presentation
Pooled safety and efficacy of inclisiran in patients with statin intolerance (ORION-10 and ORION-11)
30 August 2020
thumbnail
Congress Presentation
LDL-cholesterol variability and cardiovascular follow-Up in sitosterolemia
1 September 2025
thumbnail
Congress Presentation
Successful ESC recommended LDL-C reduction after percutaneous coronary intervention: real-world data from the contemporary ZON-HR registry.
28 August 2023
thumbnail
Congress Presentation
Time course of LDL-C lowering after initiation of PCSK9 inhibition or bempedoic acid in atherosclerotic cardiovascular disease
20 March 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources